Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: M. Ramle who wrote (1386)	11/6/1998 4:47:00 PM
From: billy d	Read Replies (3) \| Respond to of 10280

What do you guys think will happen if the OXY trials are good? I don't think anyone expects it to pass. The way these biotechs are trading any good news could send this thing rocketing past 80. One question. The news on GERN seemed to set the biotechs in motion today. What this company claims to do is something with the repairation of cells in order to cure many ailments. (please forgive my layman like definition) Now I realize GERN is quite far away from success and no doubt a sure thing but why do stocks like SEPR, who treat symptoms, rally so strongly when a company like GERN may have the key to solving so many problems leaving drugs which treat symptoms out in the cold? To me this is strange but then again so is this market.